J. Goldman & Co’s NEVRO CORP. NVRO Stock Holding History

J. Goldman & Co’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-48,078	Closed	-$1.87M	–	347
2018 Q4	$1.87M	Buy	+48,078	New	+$2.14M	0.14%	146

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

J. Goldman & Co's NVRO Position: Q1 2019 in Review

J. Goldman & Co sold out of NEVRO CORP. (NVRO) in Q1 2019, closing a stake of 48,078 shares — an estimated $1.87M sold.

J. Goldman & Co first reported a position in NVRO in Q4 2018 and held it in 1 quarter. The position peaked at $1.87M in Q4 2018. 172 funds tracked by Wall St. Rank hold NVRO as of Q1 2019.

J. Goldman & Co reported no remaining NEVRO CORP. position as of Q1 2019 after selling out during the quarter.
J. Goldman & Co sold 48,078 NEVRO CORP. shares in Q1 2019, an estimated $1.87M.
J. Goldman & Co first reported a position in NEVRO CORP. in Q4 2018 and held it in 1 quarter.
J. Goldman & Co's NEVRO CORP. position peaked at $1.87M in Q4 2018.
172 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2019.

Based on J. Goldman & Co's 13F filing for Q1 2019, filed 14 May 2019.